New medicine for orphan and Rare diseases has the capability to undoubtedly impact the lives of patients, where historically there were few or no treatments have been provided to control the sickness. The Orphan Drug Act (ODA) established in 1983 compelled producers to expand scale to treat uncommon/orphan diseases, and the orphan drug panorama has advanced drastically. Approvals for orphan drugs has doubled in the past decade, and there are over 500 applicants in the pipeline for orphan diseases.

Process of marketing does not stop with the product launch but continues thereafter to ensure enhanced customer experience and customized solutions throughout product's lifecycle. Smart marketing solutions opted by organizations contribute to the holistic view over the depth of any industry, economically and contemporarily. 

We are all experiencing turbulent times and responding in the best ways we know how. Strategy leaders are no different. The accelerated rate of change given the current environment is forcing organizations to find new ways to add business agility and speed to address increased customer and competitive demands. To accelerate decision-making, many Boards and CEOs are deploying extensive scenario planning and rapidly shifting into execution of approved initiatives that require cross-functional participation.

Witness the significant development of microbiome, probiotics and prebiotics research alongside their applications relating to difficulties like therapeutic information understanding, speculation and administrative obstacles looked by the experts. The convergence between developing innovation and disclosure with the setting of consumer intrigue. Recognize the non-distinguished dysbiosis, to find the expected territories under examination for interests in Gut and Skin microbiome and its part as an indicative instrument of drug revelation. 

Modern supply chains is facing un-precedented stress and are drawing an increased level of scrutiny. It’s time to integrate the business plans and leverage technologies for aligning procurement and supply chain and redefine the bars of success in Retail. An extra-ordinary platform that offers you a power-packed impactful insight from business leaders and innovators for winning on cross-border e-commerce, new payment methods, Digital Logistics, Blockchain, AI, Robotics, Drone and other advanced automation. 

Digital Transformation has accelerated immensely in the past few months, Fintech and Blockchain are at the center of this paradigm shift from Traditional Banking to Digital Banking. With the Financial Services and Banking sector bracing themselves for uncertain times, the industries have witnessed advanced innovations, larger investments, and greater productivity. This has led to a rise of Fintech and Blockchain Technology in the Middle East to adopt the changing economy trends. 

Technological innovation influences mission-critical applications in business processes and the manufacturing and technology companies that take the risk and are early adopters of new technology will be rewarded for their progressive decision-making. Since, digitization helps to ensure product quality and safety, as well as faster service delivery, it ensures to go a long way with customers. This has made the IoT adaptation the need of hour!
 

The 8th Edition Biomarker and Companion Diagnostics Virtual Conference scheduled to be held on 25 - 26 March 2021 would address the gaps between early stage biomarker development and the commercialization stage of biomarkers. This conference would also highlight case studies on leveraging emerging technologies in Digital Biomarkers, Precision Medicine and Big Data. 

COVID-19 has changed the business landscape for everyone. In these constantly evolving and changing times, it is essential for business organizations to stay ahead of time and create newer strategies to optimize revenue. Disruptive innovative technologies are now being introduced to overcome challenging times. To gain competitive advantage, businesses must incorporate these technologies along with long-term strategies into their business models.

As per MarketsandMarkets research analysis, the global dPCR and qPCR is estimated to grow to USD 6,270.9 million by 2024 at a CAGR of 8.8%. Factors such as the rising incidences of target infectious diseases and genetic disorders; continuous technological advancements in PCR technologies; increasing investments, funds, and grants; increasing use of biomarker profiling for disease diagnostics; and successful completion of the Human Genome Project are driving the growth of this market. However, the high instrument costs—especially that of dPCR—and the technical limitations of PCR have restricted their greater use.

5G is paving the way in many smart opportunities and is revolutionizing the technology world. Breakthrough technologies for the 5G deployment and infrastructure are going to change the game.

The conference is focused on few of the major questions such as what is the Influence of ML and AI on 5G? The privacy and security risk? How to tap into 5G monetization opportunity? Understanding business implications of booming trends of 5G